PANTOPRAZOLE SODIUM DR is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Direct Rx. The primary component is Pantoprazole Sodium.
| Product ID | 61919-806_87d995d0-83be-4778-e053-2a95a90ab8a6 |
| NDC | 61919-806 |
| Product Type | Human Prescription Drug |
| Proprietary Name | PANTOPRAZOLE SODIUM DR |
| Generic Name | Pantoprazole Sodium |
| Dosage Form | Tablet, Delayed Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-05-01 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA090074 |
| Labeler Name | DIRECT RX |
| Substance Name | PANTOPRAZOLE SODIUM |
| Active Ingredient Strength | 20 mg/1 |
| Pharm Classes | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2019-05-02 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA090074 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-02 |
| Marketing Category | ANDA |
| Application Number | ANDA090074 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-05-01 |
| Ingredient | Strength |
|---|---|
| PANTOPRAZOLE SODIUM | 20 mg/1 |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 51655-501 | Pantoprazole Sodium DR | Pantoprazole Sodium DR |
| 61919-806 | PANTOPRAZOLE SODIUM DR | PANTOPRAZOLE SODIUM DR |
| 0093-0011 | Pantoprazole Sodium | Pantoprazole Sodium |
| 0093-0012 | Pantoprazole Sodium | Pantoprazole Sodium |
| 0143-9284 | Pantoprazole Sodium | Pantoprazole Sodium |
| 0008-0841 | Protonix | PANTOPRAZOLE SODIUM |
| 0008-0843 | Protonix | PANTOPRAZOLE SODIUM |
| 0008-0844 | Protonix | PANTOPRAZOLE SODIUM |
| 0008-0923 | Protonix | PANTOPRAZOLE SODIUM |
| 0008-0941 | Protonix | pantoprazole sodium |
| 0008-2001 | Protonix | PANTOPRAZOLE SODIUM |
| 0008-4001 | Protonix | PANTOPRAZOLE SODIUM |